recent days, it is proven that there are other diseases like Parkinson's disease that do associate with genetic polymorphisms and cognitive impairment. 7 Also, gene polymorphisms have been coordinated with cerebrovascular diseases (CVD), such as atherosclerotic cerebral infarction, 8 and the etiological factors of sporadic cerebral hemorrhage in the Chinese population were the polymorphisms such as rs1800790, rs1800787, and rs6050. 9 Our study was performed to investigate at the molecular level, to get the more information on the genetic association of CAPN10 gene polymorphism with cognitive impairment of cerebral SVD in the Chinese population.
Calpains are the calcium-activated neutral proteases of the cytosolic cysteine proteinase family; they can form heterodimers composed of a large 80 kDa catalytic subunit and a common 30 kDa regulatory subunit, and dysfunction of calpains is the cause for certain diseases such as Parkinson's disease, cataract, and Alzheimer's disease. 10 Calpains are activated in response to several classes of cytokines, growth factors, lysophospholipids, and physical stresses, 11 thereby it started participating in degenerative vascular disorders, such as arteriosclerosis. 12, 13 Calpain is also involved in physiological and pathophysiological processes, including cytoskeletal reorganization, cell cycle regulation, signal transduction, and apoptosis pathway. 10 rs2736100 of CAPN10 from GG genotype works as independent risk factor which is specially associated with the presence of arteriosclerosis. 14 In addition, upregulation of CAPN10 exhibits its role in neurodegenerative diseases such as Alzheimer-type disease,
by enhancing the accumulation of β-amyloid peptide, inducing the hyperphosphorylation in the central nervous system where it degenerates the neurologic functions. 15 Moreover, it was proved that CAPN10 plays an important role in intellectual disability and cognitive impairment processes, from which we got inspired, although it is from a congenital disease perspective and the mechanism how CAPN10 works remains unclear. 16 In addition, there is a study that demonstrates the effect of CAPN10 on cerebral impairment from genetic and chromosomal perspectives. 17 Therefore, more exhaustive examination is required to explain the exact function regarding the role of CAPN10.
| MATERIAL S AND ME THODS

| Ethics statement
This study was approved by the Ethics Committee of Xiangya Hospital, Central South University and in conformity with the Helsinki declaration. And also, the informed consent was signed by all the patients and respective guardians. 
| Study subjects
| Cognitive function assessment
The cognitive function assessment was performed based on the measurement of the Mini-Mental State Exam (MMSE) score, orientation ability, memory, attention, and calculation ability, recalling memory, language ability, word sense discrimination, recitation of numbers, image free recall, meaningless graphic recognition, portrait associating recall, and trail making test A and B. All tests were carried out under the double-blind circumstances.
| Polymorphism detection
In this experiment from the patients, around 3 ml of anticoagulant venous blood was taken from which the leukocytes were separated using lymphocyte separation solution, and the extraction of genomic DNA from leukocytes was made using the conven- in water at 37°C for 16 hours; later, the restriction enzyme digestion was ended. Finally, 2% agarose gel electrophoresis was used to treat the restriction enzyme digestion and then, it was envisaged using gel imaging apparatus, where three copies of each genotype were chained and examined using Basic Local Alignment Search Tool (BLAST). Figure S1 ).
| PCR-RFLP amplification products of SNP43 (G/A) and SNP63 (T/C) loci
| Statistical analysis
Statistical analysis was conducted using SPSS 19.0 (IBM Corp.
Armonk, NY, USA). The measurement data were expressed by mean ± standard deviation, and categorical data were expressed as percentage. t test and chi-square test were used to conduct comparison of measurement data and comparison of categorical data, respectively. The genotype distribution frequency was analyzed by PLINK (http://pngu.mgh.harvard.edu/purcell/plink) and verified by
Hardy-Weinberg equilibrium. Logistic regression was used to assess odd ratios (OR) of cerebral SVD and also its 95% confidence interval (CI). The two-tailed test was considered significant if P < .05.
| RE SULTS
| Baseline characteristics of cerebral SVD patients and healthy controls
Initially, the number of cerebral SVD patients with hypertension, diabetes, and also hyperlipidemia and the cerebral SVD patients with the level of TG, TC, LDL, HDL, gender, mean age, mean BMI, and number of patients taking a sedentary life style, smoking, and drinking, and the education were evaluated. In comparison with the control group, the number of hypertension, diabetes, and also hyperlipidemia and the level of TG, TC, LDL, and HDL of the cerebral SVD patients were noticeably higher (P < .05), while there was no obvious difference between the two groups in terms of the gender, mean age, mean BMI, number of patients taking a inactive life style, smoking and drinking, and the education (P > .05). Compared with the NCI group, the level of TG, TC, LDL, and HDL of the VCI group was much higher in cerebral Loci Primer sequence
TA B L E 1 Primer sequence of SNP43 (G/A) and SNP63 (T/C) loci SVD patients (P < .05) ( Table 2 ). All results above verified that hypertension, diabetes, hyperlipidemia, TG, TC, LDL, and HDL may be associated with cerebral SVD.
| Frequency distribution of GG, GA, and AA genotype and G and A allele in the VCI and NCI groups
The distribution of genotypes and allele frequency of CAPN10 gene SNP43 (G/A) and SNP63 (C/T) loci is shown in Table 3 SNP63 (C/T) loci: distribution frequency of genotype and allele of each group was compared, respectively, being uncorrelated.
| G allele at SNP43 (G/A) is a risk factor for cognitive impairment in cerebral SVD patients
Mini-Mental State Exam is the best way to find the cognitive assessment and analysis in cerebral SVD patients, and the results are shown in Table 4 . Patients with GG genotype scored lower than patients with GA + AA genotype at SNP43 (G/A) loci in terms of the aggregate scores of MMSE, orientation ability, memory, attention and calculation ability, recall, language ability, word sense discrimination, recitation of numbers, image free recall, meaningless graphic recognition, and portrait associating recall (all P < 05), while they were scored higher in terms of trail making test A and B, and the differences were statistically significant (all P < .05). It was suggested that SNP43 (G/A) locus is an influential factor for the cognitive function of cerebral SVD patients and patients with G allele may perform relatively poor performance in cognitive function. There was no perceptible difference observed in the score of MMSE assessment and other tests attained by patients with CC genotype and patients with CT + TT genotype at SNP63 (C/T) (P > .05).
| SNP43 (G/A), TG, TC, LDL, and HDL are independent risk factors for cognitive impairment in cerebral SVD patients
With the cognitive impairment of cerebral SVD patients, and SNP43
(G/A) loci, SNP63 (C/T) loci, history of diabetes, hypertension, and hyperlipidemia, and level of TG, TC, LDL, and HDL as dependent and independent variables, respectively, a bivariate logistic regression analysis was practiced. The occurrence of cognitive impairment in cerebral SVD patients is closely related to the SNP43 (G/A) loci and the level of TG, TC, LDL, and HDL (all P < .05), which are considered as the independent risk factors for cognitive impairment in cerebral SVD patients. SNP63 (C/T) loci, hypertension history, diabetes history, and hyperlipidemia history were not considerably related to cognitive impairment in cerebral SVD patients (P > .05) ( Table 5 ).
TA B L E 2 Baseline characteristics of cerebral SVD patients and healthy controls
These results indicated that SNP43 (G/A), TG, TC, LDL, and HDL might be independent risk factors for cognitive impairment in cerebral SVD patients.
| D ISCUSS I ON
Cerebral SVD constitutes a major source of cognitive decline and neurological disorders in the elderly, and it occurs in relation multiple inherited and genetic disorders. 20, 21 Accumulating studies have reported the link between genetic polymorphism of specific genes and cerebrovascular disease, such as, the correlation of Arg972 insulin receptor substrate-1 polymorphism with risk and severity of Alzheimer's disease. 22 Also, Calpain was examined in cognitive impairment following cerebrovascular diseases because it comes to light in the early stages of the disease, 23 thus, it suggests its crucial role in the occurrence of neurodegenerative disease. In the current study, we provided evidence that CAPN10 gene polymorphism was closely associated with cerebral SVD. Our results displayed that SNP43 (G/A) GG genotype of CAPN10 was considered as the risk factor for cerebral SVD. Calpains, as very common family of the calcium-dependent cysteine proteases, were always involved in a large range of differentiation processes and cell regulation. 24 It was reported in a prior study that Calpains played a crucial role in neurodegeneration, cell motility, and also in synaptic plasticity. 25 CAPN10 protein worked on regulating pancreatic β-cell function, thermogenesis, and glucose metabolism, and several sites of CAPN10 polymorphism were undergone exhaustive research for their potential markers for the metabolic syndrome and type 2 diabetes. 26 The GG genotype of CAPN10 was associated with increased susceptibility which leads to colorectal cancer. 27 In a recent study, SNP 43 and SNP 44 polymorphisms of CAPN10 gene were proved to have effect on the variance in CAPN10 mRNA level, in which way to increase the risk of cardiovascular diseases. 28 In addition, SNP43
SNP43 (G/A) GG genotype in
has been proved for its potential role in the occurrence of type 2 diabetes where this leads to higher risk of cardiovascular disease. 29 Orho-Melander et al 30 has demonstrated the SNP-43 allele 1 was associated with elevated fasting serum insulin and homeostasis model assessment index. Notably, it has been proved that insulin resistance is a key risk factor for the increased risk of cognitive impairment. 31 Meanwhile, we also found that the allele G of SNP43 of with longer reperfusion in the areas of cerebral ischemia leading to an increase in calpain positivity.
In our study, we found that TG, TC, LDL, and HDL were closely correlated to cognitive impairment in cerebral SVD patients. Prospective and cross-sectional observational researches have studied the association between cognitive impairment and the level of serum lipids/ lipoproteins, such as TC, TG, HDL, and LDL, but these studies have demonstrated inconsistent and conflicting results. 33 A study showed that high TC and LDL-C may contribute to Alzheimer's disease, dementia, or cognitive deficits of elderly people when compared with sex-and age-matched nondemented peers, which was consistent with our findings here. 34 HDL acts as an antioxidant and represents as the most important anti atherosclerotic factors which implicates the endothelial dysfunction. 35 Alzheimer's disease, as a neurodegenerative disease, it is occurred when the level of TC levels is high, so is the cognitive impairment. 36 In addition, recent finding showed that TG level was involved and played an important role in cognitive impairment of MDD, especially in late memory. 37 Based on the results obtained in this current study, CAPN10
gene polymorphism was associated with cerebral SVD and the TA B L E 4 Analysis for the relationship between the SNP43 (G/A) and SNP63 (C/T) loci and the cognitive impairment in patients with cerebral small vessel disease allele G of SNP43 (G/A) which increased the risk of cognitive impairment in cerebral SVD, which makes it a potential molecular target for CSVD treatment. As most studies focused on cognitive impairment in Alzheimer's disease rather than in cerebral SVD, and were mostly demonstrated using the macro perspective, the efforts made in this study may provide some novel perspective.
However, the mechanism of SNP43 in cerebral SVD analyzed with larger sample sizes is required to be manifested in a more detailed way in the future.
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